Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eisai, Biogen move Alzheimer’s treatment into Phase III

pharmatimesMarch 27, 2019

Tag: Biogen , aducanumab , BAN2401

PharmaSources Customer Service